Kwame McKensie publishes his debut Mental Elf blog on a recent cross-sectional study, which explores the relationship between national mental health expenditure and quality of care in longer-term psychiatric and social care facilities in Europe.
[read the full story...]
This review of the effect of removable partial dentures (RPDs) on quality of life included 16 studies mainly retrospective and cross-sectional providing limited evidence of any association association between patient-reported QoL or satisfaction with technical or biological parameters of RPDs.
[read the full story...]
This review of the impact on oral health related quality of life (OHRQoL) linked with maintaining or restoring a shortened dental arch found limited evidence from 3 studies suggesting a benefit for OHRQoL with maintaining rather than restoring a the SDA with a removable partial dental prosthesis.
[read the full story...]
Ben Perry explores the findings of a recent systematic review looking at the effectiveness of cognitive-behavioural therapy on glycaemic control and psychological outcomes in adults with diabetes.
[read the full story...]
This update of a 2005 Cochrane review identified 23 RCTs but a limited number at low risk of bias so there is insufficient evidence to support or refute the use of any interventions in managing burning mouth syndrome.
[read the full story...]
20 studies were identified for this review of oral health related quality of life in children following general anaesthetic (GA). While a majority demonstrated an improvement following GA most are based on convenience samples and are of limited quality so more high quality research is needed.
[read the full story...]
Elizabeth Collier writes her debut blog on the REMCARE randomised controlled trial of reminiscence groups for people with dementia and their family carers.
[read the full story...]
Samei Huda mulls over a recent RCT on the effects of older and newer antipsychotics on quality of life in schizophrenia. The study finds a different result to the 10-year old CUTLASS trial; namely that second generation antipsychotics may be superior to first generation antipsychotics in terms of improving quality of life for people with schizophrenia.
[read the full story...]
Alex Langford explores the emerging findings from a recent meta-analysis looking at the efficacy and safety of antidepressants added to antipsychotics for people with schizophrenia and schizophrenia-like psychosis.
[read the full story...]
Murtada Alsaif summarises a recent 4-week long phase II randomised controlled trial of ITI-007 for the treatment of schizophrenia, which contains some positive results for this novel intervention.
[read the full story...]
